Connable Office Inc’s AstraZeneca AZN Stock Holding History

Connable Office Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Buy	5,944 +183	+3%	+$35.3K	0.12%	80
2025 Q4	$1.06M	Sell	5,761 -247	-4%	-$43.3K	0.1%	89
2025 Q3	$922K	Hold	6,008	–	–	0.09%	95
2025 Q2	$840K	Sell	6,008 -4,026	-40%	-$564K	0.08%	101
2025 Q1	$1.47M	Sell	10,034 -555	-5%	-$80.3K	0.16%	80
2024 Q4	$1.39M	Sell	10,589 -293	-3%	-$41K	0.14%	81
2024 Q3	$1.7M	Hold	10,882	–	–	0.17%	78
2024 Q2	$1.7M	Buy	10,882 +2,661	+32%	+$400K	0.18%	78
2024 Q1	$1.11M	Sell	8,221 -280	-3%	-$37.1K	0.13%	88
2023 Q4	$1.15M	Hold	8,501	–	–	0.14%	86
2023 Q3	$1.15M	Buy	8,501 +21	+0.2%	+$2.87K	0.16%	85
2023 Q2	$1.21M	Sell	8,480 -206	-2%	-$30.3K	0.17%	82
2023 Q1	$1.21M	Hold	8,686	–	–	0.18%	84
2022 Q4	$1.18M	Buy	8,686 +73	+0.8%	+$9.15K	0.17%	84
2022 Q3	$945K	Buy	+8,613	New	+$1.09M	0.15%	91
2014 Q2	–	Sell	-4,138	Closed	-$268K	–	216
2014 Q1	$268K	Sell	4,138 -742	-15%	-$47.9K	0.07%	155
2013 Q4	$290K	Sell	4,880 -491	-9%	-$26.7K	0.08%	147
2013 Q3	$279K	Hold	5,371	–	–	0.08%	185
2013 Q2	$254K	Buy	+5,371	New	+$273K	0.07%	186

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Connable Office Inc's AZN Position: Q1 2026 in Review

Connable Office Inc increased its AstraZeneca (AZN) stake by 3.2% in Q1 2026, buying an estimated $35.3K and bringing the position to 5,944 shares worth $1.17M. The position accounts for 0.12% of the portfolio, ranked #80.

Connable Office Inc first reported a position in AZN in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.7M in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Connable Office Inc held 5,944 shares of AstraZeneca worth $1.17M as of Q1 2026.
Connable Office Inc bought 183 AstraZeneca shares in Q1 2026, an estimated $35.3K.
AstraZeneca made up 0.12% of Connable Office Inc's portfolio in Q1 2026, its #80 holding.
Connable Office Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 19 quarters since.
Connable Office Inc's AstraZeneca position peaked at $1.7M in Q2 2024.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Connable Office Inc's 13F filing for Q1 2026, filed 29 Apr 2026.